Disease: Von Gierke disease
- A case of glycogen storage disease type a with gout as the first manifestation
- A case of glycogen storage disease type Ⅰa with gout as the first manifestation
- A case report of glycogen storage disease type 1a
- A glycogen storage disease type 1a patient with type 2 diabetes
- A Multidisciplinary Approach for Tophi Wounds Caused by Glycogen Storage Disease Type 1a: A Rare Case
- A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets
- A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T
- A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T
- Aberrant glucose metabolism underlies impaired macrophage differentiation in glycogen storage disease type Ib
- Amnio acid substitution at position 298 of human glucose-6 phosphatase-α significantly impacts its stability in mammalian cells
- Assessment of auditory functions in patients with hepatic glycogen storage diseases
- Assessment of the diagnosis, treatment, and follow-up of a group of Turkish pediatric glycogen storage disease type 1b patients with varying clinical presentations and a novel mutation
- Biochemistry, Glycogenesis
- Biochemistry, Glycogenesis
- Biophysical and functional properties of purified glucose-6-phosphatase catalytic subunit 1
- Blood glucose trends in glycogen storage disease type Ia: A cross-sectional study
- Body composition in patients with hepatic glycogen storage diseases
- Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy
- Clinical characteristics and genetic analysis of a Chinese pedigree affected by glycogen storage disease type Ia with gout as the first manifestation
- Clinical characteristics and long-term outcomes of patients with glycogen storage disease type 1b: a retrospective multi-center experience in Poland
- Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study
- Clinical, pathological and molecular spectrum of patients with glycogen storage diseases in Pakistan
- CRISPR/Cas9-based double-strand oligonucleotide insertion strategy corrects metabolic abnormalities in murine glycogen storage disease type-Ia
- CT findings of glycogen storage disease I complicated with pancreatitis: A case report
- Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders
- Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects?
- Dapagliflozin Prevents Kidney Glycogen Accumulation and Improves Renal Proximal Tubule Cell Functions in a Mouse Model of Glycogen Storage Disease Type 1b
- DBS are suitable for 1,5-anhydroglucitol monitoring in GSD1b and G6PC3-deficient patients taking SGLT2 inhibitors to treat neutropenia
- Dental rehabilitation in a young patient with glycogen storage disease type 1B
- Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy
- Development of minimally invasive (13)C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia
- Development of minimally invasive <sup>13</sup>C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia
- Dynamic Methods for Childhood Hypoglycemia Phenotyping: A Narrative Review
- Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire
- Elucidation of intermolecular interactions between chlorogenic acid and glucose-6-phosphate translocase: A step towards chemically induced glycogen storage disease type 1b model
- Empagliflozin in children with glycogen storage disease-associated inflammatory bowel disease: a prospective, single-arm, open-label clinical trial
- Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia Estimated by Oral D-[6,6-2H2]-glucose
- Euglycemic Diabetic Ketoacidosis Presenting as Hypoglycemia in a Patient With Type 2 Diabetes and Von Gierke's Disease
- Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients
- First report of suspected glycogen storage disease type 1a occurring in an adult dog
- Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I
- Gene therapy for glycogen storage diseases
- Genetics of severe congenital neutropenia as a gateway to personalized therapy
- Genome editing using <em>Staphylococcus aureus</em> Cas9 in a canine model of glycogen storage disease Ia
- Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia
- Glycogen Storage Disease Type I
- Glycogen Storage Disease Type I
- Glycogen storage disease type I patients with hyperlipidemia have no signs of early vascular dysfunction and premature atherosclerosis
- Glycogen Storage Disease Type I With Hypercalcemia in an Infant: A Case Report
- Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies
- Glycogen Storage Disease type IA refractory to cornstarch: Can next generation sequencing offer a solution?
- Glycogen Storage Disease Type Ia Screening Using Dried Blood Spots on Filter Paper: Application of COP-PCR for Detection of the c.648G>T G6PC Gene Mutation
- Glycogen Storage Disease Type Ia Screening Using Dried Blood Spots on Filter Paper: Application of COP-PCR for Detection of the c.648G>T G6PC Gene Mutation
- Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
- Glycogen Storage Disease Type IXb in a 3-y-old Child
- Glycogen Storage Disease: Expert Opinion on Clinical Diagnosis Revisited after Molecular Testing
- Glycogen storage diseases
- Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI
- Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib
- Impact of glycogen storage disease type I on adult daily life: a survey
- Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using (13)C-glucose breath test
- Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using <sup>13</sup>C-glucose breath test
- Inhibition of Wnt/beta-catenin signaling reduces renal fibrosis in murine glycogen storage disease type Ia
- Inhibition of Wnt/β-catenin signaling reduces renal fibrosis in murine glycogen storage disease type Ia
- Intestinal stricture in a patient with glycogen storage disease type Ib and inflammatory bowel disease
- Liver transplantation in glycogen storage disease: a single-center experience
- Long-Term Treatment of Lipoprotein Lipase Deficiency with Medium-Chain Triglyceride-Enriched Diet: A Case Series
- Modifiable factors affecting renal preservation in type I glycogen storage disease after liver transplantation: a single-center propensity-match cohort study
- Molecular and clinical profiling in a large cohort of Asian Indians with glycogen storage disorders
- Molecular mechanism underlying impaired hepatic autophagy in glycogen storage disease type Ib
- Molecular mechanisms of aberrant neutrophil differentiation in glycogen storage disease type Ib
- Molecular, Biochemical, and Clinical Characterization of Thirteen Patients with Glycogen Storage Disease 1a in Malaysia
- Multidisciplinary management of pregnancy and labour in a patient with glycogen storage disease type 1a
- Mutational analysis and clinical investigations of medically diagnosed GSD 1a patients from Pakistan
- Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report
- Parenteral Exposure of Mice to Ricin Toxin Induces Fatal Hypoglycemia by Cytokine-Mediated Suppression of Hepatic Glucose-6-Phosphatase Expression
- Pathogenic Potential of a PCK1 Gene Variant in Cytosolic PEPCK Deficiency: A Compelling Case Study
- Peripheral neuropathy caused by vitamin B(12) deficiency in a patient with glycogen storage disease type a
- Peripheral neuropathy caused by vitamin B<sub>12</sub> deficiency in a patient with glycogen storage disease type Ⅰa
- Persistent acidosis and chronic kidney disease in a patient with type 1 glycogen storage disease
- Polyadenine insertion disrupting the G6PC1 gene in German Pinschers with glycogen storage disease type Ia (GSD1A)
- Recurrent pancreatitis and sepsis in glycogen storage disease type Ia caused by complex heterozygous mutations in 2 sisters: Case report
- Report of an Iranian child with chronic abdominal pain and constipation diagnosed as glycogen storage disease type IX: a case report
- Repurposing empagliflozin in individuals with glycogen storage disease Ib: A value-based healthcare approach and systematic benefit-risk assessment
- Secondary diabetes as a rare complication of glycogen storage disease 1a: case report and review of literature
- Sensorineural hearing loss in GSD type I patients. A newly recognized symptomatic association of potential clinical significance and unclear pathomechanism
- Serum sex hormone-binding globulin levels are reduced and inversely associated with intrahepatic lipid content and saturated fatty acid fraction in adult patients with glycogen storage disease type 1a
- Short-term efficacy of empagliflozin in children with glycogen storage disease type b
- Short-term efficacy of empagliflozin in children with glycogen storage disease type Ⅰb
- SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency
- Studies on glycogen storage disease type 1a animal models: a brief perspective
- Successful Treatment of Refractory Anemia in a Patient With Glycogen Storage Disease Type Ia Undergoing Hemodialysis
- Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5
- Systematic literature review of the epidemiology of glycogen storage disease type 1a
- Three novel SLC37A4 variants in glycogen storage disease type 1b and a literature review
- Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop
- Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre
- Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I
- Urine-Derived Epithelial Cells as a New Model to Study Renal Metabolic Phenotypes of Patients with Glycogen Storage Disease 1a
- Von Gierke Disease (Glycogen Storage Disease Type I) and Life-Threatening Abdominal Aortic Aneurysm: A Case Report of an Extremely Rare Condition